Erbitux Label Update Includes Lengthened Observation For Infusion Reactions
This article was originally published in The Pink Sheet Daily
Executive Summary
Corresponding Bristol/ImClone “Dear Doctor” letter also describes new labeling language on severe electrolyte depletion observed in ongoing clinical trials of the colorectal cancer drug.